Polpharma Biologics Announces Global Commercialization Deal fo...
GDANSK, Poland, Sept. 3, 2019 /PRNewswire-AsiaNet/ -- Polpharma Biologics S.A. ("Polpharma Biologics") today announces that it has entered a global commercialization agreement with Sandoz AG for a natalizumab biosimilar. The medicine is currently in Phase III clinical development for the treatment of...
Authors: LATEST ASIANET NEWS RELEASES